targeted error correction sequencing
Jump to navigation
Jump to search
Clinical significance
- developed to detect circulating cell-free DNA from many early tumors[1]
- method of cell-free DNA in plasma
More general terms
References
- ↑ 1.0 1.1 Phallen J, Sausen M, Adleff V et al Direct detection of early-stage cancers using circulating tumor DNA. Science Translational Medicine. 16 Aug 2017: 9(403):eaan2415 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/28814544 <Internet> http://stm.sciencemag.org/content/9/403/eaan2415